ModelEdge
Landos Biopharma Inc.
LABP
Filing type
8-K
Filing date
May 22, 2024
Updated
May 23, 2024 ยท 2:29 PM

Filing

8-KCompleting Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events

Exhibits

EX-3.1EX-3.1EX-3.2EX-3.2EX-99.1Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other EventsGRAPHICGraphic